


Spago Nanomedical Revenue
Biotechnology Research • Lund, Skåne County, Sweden • 11-20 Employees
Spago Nanomedical revenue & valuation
| Annual revenue | $1,539,990 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $5,000,000 |
| Total funding | No funding |
Key Contacts at Spago Nanomedical
Mats Hansen
Ceo
Mikael Von Euler
Member Board Of Directors
Company overview
| Headquarters | Scheelevägen 22, Lund, SE-223 63, SE |
| Phone number | +464681188 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Drug Delivery And Pegylation, Mri Contrast Agent Development, Nanomedicine For Cancer Diagnosis And Treatment |
| Founded | 2007 |
| Employees | 11-20 |
| Socials |
Spago Nanomedical Email Formats
Spago Nanomedical uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@spagonanomedical.se), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@spagonanomedical.se | 100% |
About Spago Nanomedical
Spago Nanomedical is a Swedish biotechnology company developing products for precision imaging and radionuclide treatment of cancer and other devastating diseases. The company´s two main development programs, SpagoPix and Tumorad, are based on a unique and proprietary platform for physiological accumulation of optimized and functionalized polymeric particles in tumors. Candidate drug SN132D is a gadolinium-free contrast agent for precision magnetic resonance imaging (MRI) with exceptionally high signal strength. By selective physiological accumulation in tumor tissue, SpagoPix meets a well recognized need for significantly improved soft tissue tumor imaging with further potential in inflammatory endometriosis. Candidate drug 177Lu-SN201 is a novel radiopharmaceutical nanoprticle with potential to expand the scope of radionuclide therapy in solid tumor indications not currently targetable by other modalities, as monotherapy or in combinations with established treatments.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Spago Nanomedical has 7 employees across 6 departments.
Departments
Number of employees
Funding Data
Spago Nanomedical has never raised funding before.
Spago Nanomedical Tech Stack
Discover the technologies and tools that power Spago Nanomedical's digital infrastructure, from frameworks to analytics platforms.
Security
JavaScript libraries
Font scripts
JavaScript libraries
Web servers
Miscellaneous
Programming languages
Blogs
Analytics
Video players
Cookie compliance
Frequently asked questions
4.8
40,000 users



